Z250-1322 Screening compound: 2-[(1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}piperidin-3-yl)formamido]acetamide

Z250-1322 Screening compound: 2-[(1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}piperidin-3-yl)formamido]acetamide
Z250-1322 Screening compound: 2-[(1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}piperidin-3-yl)formamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Z250-1322
2-[(1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}piperidin-3-yl)formamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Z250-1322

Molecular Formula

C20H21N5O3S (C20 H21 N5 O3 S)

Compound Name

2-[(1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}piperidin-3-yl)formamido]acetamide

IUPAC name

2-[(1-{4-oxo-7-phenyl-3H4H-thieno[32-d]pyrimidin-2-yl}piperidin-3-yl)formamido]acetamide

SMILES

NC(CNC(C(CCC1)CN1C(NC1=O)=Nc2c1scc2-c1ccccc1)=O)=O

InChI

InChI=1S/C20H21N5O3S/c21-15(26)9-22-18(27)13-7-4-8-25(10-13)20-23-16-14(12-5-2-1-3-6-12)11-29-17(16)19(28)24-20/h1-3,5-6,11,13H,4,7-10H2,(H2,21,26)(H,22,27)(H,23,24,28)/t13-/m0/s1

InChI Key

BKPJBLAIZOIXOX-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD27636850

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.220

Distribution Coefficient, logD

1.220

Water Solubility, LogSw

-2.29

Polar Surface Area

94.458

Acid Dissociation Constant (pKa)

11.09

Base Dissociation Constant (pKb)

0.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.00

Z250-1322 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

KRAS-Targeted Library (16000 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with Z250-1322 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Z250-1322?
Check Price and Availability of Z250-1322, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Z250-1322 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Z250-1322
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Z250-1322
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Z250-1322 available by request